All AbMole products are for research use only, cannot be used for human consumption.
Species: Human
Purity: SDS-PAGE analysis > 97%, HPLC analysis > 97%
Endotoxin: protein content < 1 EU/μg by LAL method
Theoretical molecular weight: 7.9 kDa
Storage and stability: After receiving, the product remains stable at -70°C or -20°C for up to 6 months. After recombination, the product should be stable at 4°C for 1 week or -20°C for 3 months. Avoid repeated freeze-thaw cycles
Bioactivity: Fully bioactive compared to the standard. Bioactive concentrations were determined by chemotactic bioassay of human T lymphocytes in the range of 1.0-10.0 ng/ mL. CCL18 cDNA encodes a precursor protein with an 89AA residue that contains a 20AA signal peptide that is cleaved to produce a 69AA residue mature protein that lacks potential glycosylation sites. In vitro, THE expression of CCL18 mRNA was induced and IFN-γ was inhibited in macrophages alternately activated by Th2 cytokines IL-4, IL-10 and IL-13. Gm-csf/IL-4 induced monocyte derived dendritic cells also expressed CCL18 mRNA. In vivo, CCL18 is highly expressed in lung and placenta, but not in epidermal Langerhans cells. Recombinant CCL18 has been shown to attract primary T cells, but not monocytes or neutrophils.
| Solubility (25°C) | Reconstitute the lyophilized powder in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/ml. |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related Cytokines and Growth Factors Products |
|---|
| Recombinant Human HGF (CHO-expressed)
Recombinant human Hepatocyte Growth Factor (rhHGF) , also known as hepatopoietin-A and scatter factor, is a pleiotropic mitogen belonging to the peptidase S1 family (plasminogen subfamily). It is produced by mesenchymal cells and acts on epithelial cells, endothelial cells and haemopoietic progenitor cells. |
| Recombinant Human RIPK3 Protein (E. coli, N-His)
RIPK3 is a kinase that controls necroptosis and apoptosis. In necroptosis, activated by TNF-α and ZBP1, RIPK3 phosphorylates MLKL, leading to membrane damage. Necroptosis is dependent on receptor-interacting protein kinase 3 (RIPK3), a protein shown to play an important role in experimental models of critical illness. RIPK3 promotes kidney tubular injury via mitochondrial dysfunction. The FAO-dependent RIPK3 mediates pathogenesis of acute lung injury. |
| Recombinant Influenza B Hemagglutinin/HA Protein (HEK293, C-His)
Recombinant Influenza B Hemagglutinin / HA Protein is a homotrimer that recognizes target cells in vertebrates and does so by binding to salivary acid-containing receptors on these cells. When it binds to the target cell, it causes the host inner membrane to fuse with the viral membrane, thereby facilitating the entry of the viral genome into the target cell. |
| Recombinant Human FGF-9 (E. coli)
Fibroblast Growth Factor-9 (FGF-9) is a heparin binding growth factor that belongs to the fibroblast growth factor (FGF) family. ED50 < 2.0 ng/ mL, determined by 3T3 cell proliferation assay, corresponding to > 5.0× 105 units/mg. |
| Recombinant Human CXCL13/BCA-1 (E. coli)
CXCL13, also known as B-lymphocyte chemoattractant (BLC), is a CXC chemokine that is constitutively expressed in secondary lymphoid organs. Recombinant human CXCL13 is a single non-glycosylated polypeptide chain containing 87 amino acids and mature human BCA-1 shares 64 % amino acid sequence similarity with the murine protein and 23–34 % amino acid sequence identity with other known CXC chemokines. Determined by a chemotaxis bioassay using human B cells, the biological activity is in a concentration range of 1.0-10 ng/ml. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
